NuSynth Technologies Raises ₹36.5 Crore in Funding Round Led by Avaana Capital and Shastra VC

NuSynth Technologies Raises ₹36.5 Crore

NuSynth Technologies, a Mysuru-based startup focused on chemical process innovation, has raised ₹36.5 crore in a funding round co-led by Avaana Capital and Shastra VC.

The investment, equivalent to approximately $4 million, will support the company’s efforts to develop more cost-efficient and sustainable ways to manufacture complex chemicals.

The startup is building a platform designed to identify simpler and more efficient chemical production routes. Its approach focuses on rethinking conventional manufacturing processes to improve efficiency and reduce the cost of producing specialised chemicals.

Who Founded NuSynth Technologies?

NuSynth Technologies was founded by Poorvank Purohit and Abhishek Deo, who are working to develop technology-led solutions for chemical manufacturing.

The founders told The Economic Times that the company is building a platform to find simpler, cheaper and more efficient ways to produce chemicals.

The company’s leadership team also includes Dr Ramesha AR as chief technology officer, Dipak Bajaj as chief operating officer and Abhishek Deo as chief business officer, according to the company photograph and information published with the funding report.

What Does NuSynth Technologies Do?

NuSynth focuses on chemical process innovation, particularly the development of more efficient ways to manufacture complex and specialised chemicals.

Chemical manufacturing can involve multiple reactions, processing stages, raw materials and energy-intensive operations. Finding a simpler production route can potentially reduce manufacturing costs, improve process efficiency and lower the environmental footprint of production.

NuSynth is developing a research-led platform that aims to identify improved chemical synthesis routes. Shastra VC describes the company as a research and development-focused speciality chemicals business building proprietary process intellectual property in India for pharmaceutical and electronic chemicals, using first-principles redesign and an AI engine.

Avaana Capital and Shastra VC Lead the Funding Round

The funding round was co-led by Avaana Capital and Shastra VC, two investors with interests in technology-driven businesses.

Avaana Capital invests in businesses addressing challenges related to climate, sustainability and resource efficiency. Shastra VC focuses on frontier technology, deep science and companies developing proprietary technological capabilities.

Their participation brings financial backing to a startup working at the intersection of chemical manufacturing, research and industrial innovation.

The investment also reflects investor interest in businesses seeking to improve established industrial processes through technology rather than relying solely on conventional manufacturing methods.

Why Is Chemical Process Innovation Important?

Chemical manufacturing plays an important role in industries such as pharmaceuticals, electronics, agriculture, materials and consumer products.

However, developing a commercially viable chemical process can require extensive experimentation, specialised equipment, careful process optimisation and attention to safety and environmental requirements.

A more efficient synthesis route can offer several potential benefits:

• Lower production costs: Reducing the number of steps or improving reaction efficiency may lower manufacturing expenses.

• Better resource utilisation: Improved processes may reduce the use of raw materials, solvents and energy.

• Reduced waste: More selective reactions and efficient processing can potentially reduce unwanted by-products.

• Greater manufacturing efficiency: Optimised processes can help companies improve production consistency and throughput.

• Stronger domestic capabilities: Proprietary process technology can help Indian companies build expertise in specialised chemical manufacturing.

These are potential benefits of chemical process innovation generally; the actual results for NuSynth will depend on the processes it develops and their performance at commercial scale.

Can AI Help Improve Chemical Manufacturing?

Artificial intelligence and computational methods are increasingly being explored in scientific research and industrial process development.

In chemical manufacturing, technology platforms can help researchers explore potential synthesis routes, assess process variables and identify opportunities for optimisation. However, proposed routes still need appropriate scientific validation, laboratory testing, safety assessment and scale-up before commercial use.

Shastra VC’s portfolio description identifies NuSynth as a company combining first-principles redesign with an AI engine to develop proprietary process technology.

The company’s ability to translate research into reliable, cost-effective production processes will be an important factor in determining its commercial progress.

What Could the Fresh Funding Help NuSynth Achieve?

The ₹36.5 crore funding round gives NuSynth additional capital to advance its technology development and chemical process innovation efforts.

For a research-led startup, funding can support activities such as laboratory research, process development, technical hiring, validation and preparation for commercial deployment. The precise allocation of the latest funding has not been publicly detailed in the available report, so these should be viewed as potential uses rather than confirmed spending plans.

The company’s broader objective is to identify production routes that are simpler, more economical and more efficient than existing alternatives.

Its progress will depend on the technical performance of its platform, the ability to validate new processes and demand from potential industrial customers.

What NuSynth’s Fundraise Means for India’s Deep-Tech Ecosystem

NuSynth operates in a segment where innovation often depends on specialised scientific knowledge and sustained research investment.

Unlike software businesses that may scale primarily through digital distribution, chemical process technology companies typically need to validate their solutions in physical environments and demonstrate that they can work reliably under industrial conditions.

Funding from specialist investors can help such startups move from research and development towards commercial application.

NuSynth’s fundraise adds to investor activity in India’s deep-tech and industrial innovation ecosystem, particularly in businesses seeking to develop proprietary technology for established industries. However, funding alone does not establish commercial success; the long-term outcome will depend on execution, technology validation and market adoption.

Key Takeaways

• NuSynth Technologies has raised ₹36.5 crore, or approximately $4 million.

• The funding round was co-led by Avaana Capital and Shastra VC.

• The startup is based in Mysuru and focuses on chemical process innovation.

• Founders Poorvank Purohit and Abhishek Deo are developing a platform to identify simpler and more efficient chemical production methods.

• Shastra VC describes NuSynth as a research-led speciality chemicals company building proprietary process technology for pharmaceutical and electronic chemicals.

• The company aims to improve the cost efficiency and sustainability of complex chemical manufacturing.

• The precise allocation of the latest funding has not been publicly detailed in the available report.

Bottom Line

NuSynth Technologies’ ₹36.5 crore fundraise, co-led by Avaana Capital and Shastra VC, will support a startup working to rethink how complex chemicals are manufactured. Its focus on research-led process innovation and proprietary technology addresses an important industrial challenge: producing specialised chemicals more efficiently and economically.

The company’s next milestone will be demonstrating that its technology can deliver reliable, cost-effective results in practical manufacturing settings.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.